The goal of acute treatment of an hereditary angioedema (HAE) attack is to reduce its duration and severity and thus limit its impact on the patient’s functional ability and prevent a potentially ...

On-demand or acute treatment for hereditary angioedema (HAE) attacks is crucial for getting your symptoms under control quickly. In some cases, it could even be lifesaving. Heres what you need to know ...

Advances in hereditary angioedema attack prophylaxis have provided more options for patients than ever before, with multiple agents available for long-term prevention. "The treatment landscape for ...

Editor's note: This article has been updated to note that this drug is the first oral on-demand drug for treating hereditary angioedema while Orladeyo (berotralstat) was the first oral treatment ...

For many decades since its initial characterization by Sir William Osler in 1888, hereditary angioedema (HAE) attacks could only be managed symptomatically and there was no way to prevent occurrence ...

The Food and Drug Administration on Thursday approved a drug Ionis Pharmaceuticals developed for the rare genetic disease hereditary angioedema, making the therapy, known as donidalorsen, the third ...

Hereditary angioedema (HAE) is a rare genetic disorder involving a mutation in the C1 esterase inhibitor gene. This causes unpredictable attacks of severe swelling in your arms, legs, hands, feet, ...

BioCryst Pharmaceuticals, Inc. announced promising new data regarding their oral prophylactic treatment, ORLADEYO (berotralstat), for hereditary angioedema (HAE) during the 14th C1-Inhibitor ...

Hereditary angioedema (HAE) is a rare condition that causes fluid to build up throughout your body, triggering sudden and repeated serious swelling. This is the most common type and happens because of ...

For the second time in under 3 weeks, the FDA has approved a treatment for the inherited genetic disorder characterized by recurrent episodes of severe swelling. The approval is especially significant ...

A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

A new study shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks for those with hereditary angioedema. Hereditary ...